Professor of Medicine, Harvard Medical School
Director, Transplant Infectious Disease and Compromised Host Service
Associate Director, Transplant Center, Massachusetts General Hospital

Jay A. Fishman, M.D., FACP, FAST, FIDSA is Professor of Medicine at Harvard Medical School, Director of the Transplant Infectious Diseases Program at the Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center. Dr. Fishman completed medical school at Johns Hopkins University School of Medicine, internal medicine training and Infectious Disease Fellowship at MGH, and Fellowships in Molecular Biology and Genetics at MGH and Harvard Medical School. Dr. Fishman established the Transplant and Immunocompromised Host Program of the MGH, the first such training program worldwide which has trained many leaders in this field. He established Transplant Infectious Disease as an essential component of Transplant programs. His clinical expertise spans infectious diseases and immunology of solid organ and stem cell transplant recipients and has defined approaches to managing infectious risk in allo- and xenotransplantation. His research defined the use of ganciclovir for cytomegalovirus infection in transplant recipients. His background in immunology, virology and molecular biology led to the cloning of surface antigens of human Pneumocystis, and to studies of porcine cytomegalovirus and porcine endogenous retrovirus (PERV) in xenotransplantation. He has over 300 peer-reviewed publications and is internationally recognized as a clinician-educator and scientist. He is Past-President of the American Society of Transplantation and is President-elect of the International Xenotransplantation Association. He has received career achievement awards from AST and TTS.

Infectious Diseases Physician
Alfred Health & Monash University

Dr. Brad Gardiner, MBBS, MS, PhD, FRACP is an Infectious Diseases Physician and clinical researcher at Alfred Health/Monash University in Melbourne, Australia. He is interested in the prevention, early diagnosis and optimal treatment of infections in immunosuppressed patients particularly solid organ transplant recipients. He recently completed his PhD which was focused on the individualization of CMV prevention and management strategies in transplant recipients.

Current Medical Director and former Chief of Nephrology Department
Hospital Universitario 12 de Octubre

He is currently the Medical Director at Hospital Universitario 12 de Octubre, Madrid, Spain. He has been the Chief, Nephrology Dept. at Hospital del Mar, Barcelona 2009-2021) and then had the same position at 12 de Octubre. He is co-author of >350 peer-reviewed journal articles, covering all areas of nephrology (citations >18.000, h-factor 68).

He has a long trajectory as clinical research leader in industry-sponsored and investigator-driven projects with many collaborative efforts. His main research interests include all the nephrological important topics, but are mainly focused on clinical immunosuppression and kidney transplantation in the elderly and frail renal patient.

He has been a Board member of the transplantation group within the ERA, member of the European Best Renal Practices Group and KDIGO developing guidelines for kidney transplantation. He is a member of the major nephrology and transplantation societies and is on the editorial boards of several relevant scientific journals.